AusBiotech signs agreement with Indian counterpart
Wednesday, 13 October, 2004
Biotechnology industry association AusBiotech has signed a memorandum of understanding with its Indian counterpart, the Association of Biotechnology Led Enterprises (ABLE).
The MoU is expected to strengthen ties between the two countries, and open partnering and collaboration opportunities.
AusBiotech's executive director, Tony Coulepis, said the Indian biotechnology industry was expected to reach 50 per cent of the size of the US market in the next 20 years. "India is emerging as the new destination for building a globally competitive biotech industry," he said.
Coulepis said the Indian relationship was a pillar of AusBiotech's new three-year business plan, 'Globalising Australian Biotechnology', and that a relationship between the two countries would help to unlock potential in the region. An Indian business mission is expected to visit AusBiotech's national conference in Brisbane next month.
New directors
Meanwhile, AusBiotech has elected a new team of directors at its recent AGM. They are:
- Carolyn Beasley, MD of Enterix Australia.
- Michael Gilbert, GM of the Australian Centre for Plant Functional Genomics.
- Mikael Hirsch, CSIRO biotechnology strategy coordinator.
Venter joins club
Genomics pioneer J Craig Venter has just been named to present at Club Biodiversity, a satellite event to this year's AusBiotech conference.
Venter, one of the key personalities behind the Human Genome Project, is currently following in the footsteps of the great scientific voyages of the 18th and 19th centuries, capturing the DNA of specimens and sending them off to be sequenced and analysed. His yacht, Sorcerer II, is currently in Australia.
Club Biodiversity will be held at Cairns on Friday, November 12.
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
Archer completes potassium sensing alpha prototype
Quantum technology company Archer Materials Limited has developed an early Biochip prototype...
